BioCentury | Oct 8, 2007
Company News

GammaCan, DCI Biologicals Inc., Life Therapeutics deal

...company plans to begin a Phase I/II trial in 1H08. Financial terms were not disclosed. GammaCan International Inc....
BioCentury | Aug 13, 2007
Clinical News

VitiGam regulatory update

...co-develop the agent with Life Therapeutics Ltd. (ASX:LFE, Atlanta, Ga.) (see BioCentury, Aug. 28, 2006). GammaCan International Inc....
BioCentury | Nov 20, 2006
Company News

GammaCan board of directors update

...independent consultant Resigned: Chairman Lior Soussan-Gutman and Jean-Pierre Elisha Martinez, while remaining directors of GCAN's GammaCan...
BioCentury | Nov 17, 2006
Company News

GammaCan names Katz chairman

Cancer company GCAN appointed Steven Katz as chairman. Katz is president of consulting firm Steven Katz & Associates. He replaces Lior Soussan-Gutman, who will continue as a director of a GCAN subsidiary. On Thursday, GCAN...
BioCentury | Nov 6, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Lynn Schuchter, program leader of the clinical investigations program at University of Pennsylvania's Abramson Cancer Center WIR Staff cancer...
BioCentury | Sep 25, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Pearl Grimes, director of the Vitiligo and Pigmentation Institute of Southern California and clinical professor of dermatology at the University of California at Los Angeles...
BioCentury | Sep 11, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Richard Spritz, professor of pediatrics, biochemistry and molecular genetics at the University of Colorado Health Science Center WIR Staff...
BioCentury | Aug 28, 2006
Company News

GammaCan International, Life Therapeutics deal

...will share development costs and resulting profits. GCAN's first-generation GCAN101 is in Phase II testing. GammaCan...
BioCentury | May 1, 2006
Company News

GammaCan management update

GammaCan International Inc. (GCAN), Givat Shmuel, Israel Business: Cancer Hired: Patrick Schnegelsberg as CEO, formerly director of investment banking for Global Capital Markets Group; he replaces acting CEO Vered Caplan, who remains CEO of GCAN's...
BioCentury | Apr 25, 2006
Company News

GammaCan names Schnegelsberg CEO

Cancer company GCAN hired Patrick Schnegelsberg as CEO. Previously, Schnegelsberg was director of investment banking for Global Capital Markets Group. He replaces acting CEO Vered Caplan, who will remain CEO of GCAN's Israeli subsidiary. On...
Items per page:
1 - 10 of 15
BioCentury | Oct 8, 2007
Company News

GammaCan, DCI Biologicals Inc., Life Therapeutics deal

...company plans to begin a Phase I/II trial in 1H08. Financial terms were not disclosed. GammaCan International Inc....
BioCentury | Aug 13, 2007
Clinical News

VitiGam regulatory update

...co-develop the agent with Life Therapeutics Ltd. (ASX:LFE, Atlanta, Ga.) (see BioCentury, Aug. 28, 2006). GammaCan International Inc....
BioCentury | Nov 20, 2006
Company News

GammaCan board of directors update

...independent consultant Resigned: Chairman Lior Soussan-Gutman and Jean-Pierre Elisha Martinez, while remaining directors of GCAN's GammaCan...
BioCentury | Nov 17, 2006
Company News

GammaCan names Katz chairman

Cancer company GCAN appointed Steven Katz as chairman. Katz is president of consulting firm Steven Katz & Associates. He replaces Lior Soussan-Gutman, who will continue as a director of a GCAN subsidiary. On Thursday, GCAN...
BioCentury | Nov 6, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Lynn Schuchter, program leader of the clinical investigations program at University of Pennsylvania's Abramson Cancer Center WIR Staff cancer...
BioCentury | Sep 25, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Pearl Grimes, director of the Vitiligo and Pigmentation Institute of Southern California and clinical professor of dermatology at the University of California at Los Angeles...
BioCentury | Sep 11, 2006
Company News

GammaCan scientific advisory board update

GammaCan International Inc. (GCAN), Kiryat Ono, Israel Business: Cancer Appointed: Richard Spritz, professor of pediatrics, biochemistry and molecular genetics at the University of Colorado Health Science Center WIR Staff...
BioCentury | Aug 28, 2006
Company News

GammaCan International, Life Therapeutics deal

...will share development costs and resulting profits. GCAN's first-generation GCAN101 is in Phase II testing. GammaCan...
BioCentury | May 1, 2006
Company News

GammaCan management update

GammaCan International Inc. (GCAN), Givat Shmuel, Israel Business: Cancer Hired: Patrick Schnegelsberg as CEO, formerly director of investment banking for Global Capital Markets Group; he replaces acting CEO Vered Caplan, who remains CEO of GCAN's...
BioCentury | Apr 25, 2006
Company News

GammaCan names Schnegelsberg CEO

Cancer company GCAN hired Patrick Schnegelsberg as CEO. Previously, Schnegelsberg was director of investment banking for Global Capital Markets Group. He replaces acting CEO Vered Caplan, who will remain CEO of GCAN's Israeli subsidiary. On...
Items per page:
1 - 10 of 15